Koios Medical, Inc. — Form D/A

Koios Medical, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2024-06-24. The offering totals $500K, of which $170K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
CHRISTINE CHAD LIDirectorSINGAPORE, U0
GREGORY CHAD MORANDirectorCOLUMBUS, OH
ROBERT CHAD MCCLENNANDirectorNEW YORK, NY
ROBERT CHAD MCCLENNANExecutive OfficerNEW YORK, NY
ROBERT CHAD MCCLENNANPromoterNEW YORK, NY
GRAHAM ANDERSONExecutive OfficerNEW YORK, NY
GRAHAM ANDERSONPromoterNEW YORK, NY
MARK CHAD GLASGOLDDirectorPRINCETON, NJ
John Li WalkerExecutive OfficerNew York, NY
John Li WalkerPromoterNew York, NY
Robert Li McClennanExecutive OfficerNew York, NY
Robert Li McClennanPromoterNew York, NY
Gregory Li MoranDirectorColumbus, OH
Christine Li ShulingExecutive OfficerChiyoda-ku, Tokyo, M0
Christine Li ShulingPromoterChiyoda-ku, Tokyo, M0
Mark Li GlasgoldDirectorPrinceton, NJ
Gregory E MoranDirectorColumbus, OH
Mark E GlasgoldDirectorPrinceton, NJ
William E PetersonDirectorFairfax, VA

Other filings by this issuer (6)

FiledFormOfferingSold
2025-12-23D
2024-05-28D$500.0M$130.0M
2023-02-17D$12.0M$8.0M
2022-08-08D$5.0M$2.6M
2021-02-03D$3.0M$280K
2019-01-11D$11.0M$5.0M

More